These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10341765)

  • 1. [The liver side effects of azathioprine].
    Böker KH
    Dtsch Med Wochenschr; 1999 Apr; 124(17):541. PubMed ID: 10341765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatic veno-occlusive disease associated to the use of azathioprine in a renal transplant recipient].
    Hola K; Brahm J; Alvo M; Cotera A; Passalacqua W; Smok G
    Rev Med Chil; 1996 Dec; 124(12):1489-91. PubMed ID: 9334484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine induced hepatic veno-occlusive disease in systemic lupus erythematosus.
    Praprotnik S; Hocevar A; Ferlan-Marolt V; Tomsic M
    Lupus; 2005; 14(6):493-4. PubMed ID: 16038116
    [No Abstract]   [Full Text] [Related]  

  • 4. Azathioprine-induced hepatic sinusoidal obstruction syndrome.
    Galeano Valle F; Muñoz Roldán I; Donis Sevillano E
    Med Clin (Barc); 2018 Aug; 151(3):127-128. PubMed ID: 29496246
    [No Abstract]   [Full Text] [Related]  

  • 5. Azathioprine-induced hepatic veno-occlusive disease in a renal transplant recipient: histological regression following azathioprine withdrawal.
    Kohli HS; Jain D; Sud K; Jha V; Gupta KL; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1671-2. PubMed ID: 8856241
    [No Abstract]   [Full Text] [Related]  

  • 6. Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathioprine.
    Holtmann M; Schreiner O; Köhler H; Denzer U; Neurath M; Galle PR; Höhler T
    Dig Dis Sci; 2003 Aug; 48(8):1503-5. PubMed ID: 12924643
    [No Abstract]   [Full Text] [Related]  

  • 7. Veno-occlusive disease of the liver after lung transplantation.
    de Fontbrune FS; Mal H; Dauriat G; Brugière O; Biondi G; Taillé C; Valla D; Castier Y; Fournier M
    Am J Transplant; 2007 Sep; 7(9):2208-11. PubMed ID: 17697264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic veno-occlusive disease associated with immunosuppressive cyclophosphamide dosing and roxithromycin.
    Beltinger J; Haschke M; Kaufmann P; Michot M; Terracciano L; Krähenbühl S
    Ann Pharmacother; 2006 Apr; 40(4):767-70. PubMed ID: 16595573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine induced hepatic veno-occlusive disease in rheumatoid arthritis.
    Lemley DE; DeLacy LM; Seeff LB; Ishak KG; Nashel DJ
    Ann Rheum Dis; 1989 Apr; 48(4):342-6. PubMed ID: 2712618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinusoidal dilatation: a rare side effect of azathioprine.
    Jacobi AM; Feist E; Rudolph B; Burmester GR
    Ann Rheum Dis; 2004 Dec; 63(12):1702-3. PubMed ID: 15547102
    [No Abstract]   [Full Text] [Related]  

  • 11. Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis.
    Russmann S; Zimmermann A; Krähenbühl S; Kern B; Reichen J
    Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):287-90. PubMed ID: 11293451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peliosis hepatis as the cause of liver affection in a patient treated with immunosuppressive agents].
    Knudsen AH
    Ugeskr Laeger; 2002 Jun; 164(24):3215-6. PubMed ID: 12082771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature.
    Adler M; Delhaye M; Deprez C; Hardy N; Gelin M; De Pauw L; Vereerstraeten P; Cremer M; Toussaint C
    Nephrol Dial Transplant; 1987; 2(3):183-8. PubMed ID: 3114679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine side effects in the treatment of chronic inflammatory bowel disease.
    González Lara V; Pérez Calle JL
    Rev Esp Enferm Dig; 2001 Dec; 93(12):765-8. PubMed ID: 11995358
    [No Abstract]   [Full Text] [Related]  

  • 15. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome.
    Helmy A
    Aliment Pharmacol Ther; 2006 Jan; 23(1):11-25. PubMed ID: 16393276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
    Schumann M; Preiss JC; Loddenkemper C; Günther U; Somasundaram R; Siegmund B; Zeitz M
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1897-900. PubMed ID: 18788068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azathioprine-induced destructive cholangitis.
    Sobesky R; Dusoleil A; Condat B; Bedossa P; Buffet C; Pelletier G
    Am J Gastroenterol; 2001 Feb; 96(2):616-7. PubMed ID: 11232733
    [No Abstract]   [Full Text] [Related]  

  • 18. Patients with inflammatory bowel disease: their response to information leaflets about medical therapy in particular azathioprine.
    Ward B; Shah S; Eaden JA; Mayberry JF
    Arq Gastroenterol; 1998; 35(4):264-6. PubMed ID: 10347709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients.
    van Dieren JM; van Vuuren AJ; Kusters JG; Nieuwenhuis EE; Kuipers EJ; van der Woude CJ
    Gut; 2005 Nov; 54(11):1664. PubMed ID: 16227370
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month.
    Schouten van der Velden AP; Punt CJ; Van Krieken JH; Derleyn VA; Ruers TJ
    Eur J Surg Oncol; 2008 Mar; 34(3):353-5. PubMed ID: 17207961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.